Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: pharma
The IPA and Bayh-Dole on nonprofit assignment of subject inventions, 2
We have looked at the IPA assignment clause. Since the IPA is specific to nonprofits, there’s no reason to call out nonprofitedness. But there is a reason then to restrict any later invention assignment to nonprofit assignees. Why? The point … Continue reading
Reflections on Shill Reflections on Bayh-Dole, 7: Grubbers, innovation, and march-in
Reflections on Bayh-Dole by “industry leaders”–who are, apparently, mostly shills out shilling for (and to) the pharmaceutical industry. Good shilling earns shillings, so it is a viable career choice. We use these shills reflecting on Bayh-Dole to also reflect on … Continue reading
The Purpose of Bayh-Dole: Effects
Bayh-Dole re-establishes a pipeline of patent monopolies on federally supported inventions in public health running from federal agencies to the U.S. pharmaceutical industry. This patent pipeline operates directly from federal agencies granting exclusive licenses (35 USC 207-209) and through nonprofit … Continue reading
Posted in Bayh-Dole
Tagged Bayh-Dole, patent monopoly, pharma
Comments Off on The Purpose of Bayh-Dole: Effects
Who Owns Digital Learning Resources?–3
Plotkin moves on to make another good point–that “Big Pharma is the Model.” And it is–but the model is something other than the Cohen-Boyer patents that Plotkin launches into. Plotkin does not appear to recognize that Cohen-Boyer gene-splicing inventions were … Continue reading
Posted in Bayh-Dole
Tagged Bayh-Dole, Department of Education, pharma, plotkin
Comments Off on Who Owns Digital Learning Resources?–3
Bayh-Dole’s preemption of public purposes to re-establish a patent monopoly pipeline
I wrote a Twitter thread in retweeting this observation. Erin (Eeks) Stair @DrErinkate Don’t forget about Bayh-Dole, passed in the 80s, which enabled the #NIH to use our tax dollars to fund drug research at institutions & businesses; allow them … Continue reading
The National Patent Planning Commission argument for government-created private patent monopolies, 3
The National Patent Planning Commission quotes administration officials repeating this same argument. Here’s the Under Secretary of Agriculture (1941): The commercial exploitation of new inventions requires, in many cases, the expenditure of large sums of money. In such a case, … Continue reading
Posted in History, Innovation, Policy
Tagged invention, National Patent Planning Commission, patent, pharma, Vannevar Bush
Comments Off on The National Patent Planning Commission argument for government-created private patent monopolies, 3